Elon Musk’s drug use in 2024 has raised many questions, from “Did Elon Musk use ketamine daily?” to “How did his drug habits impact Tesla and SpaceX?” According to a revealing report by The New York Times, Musk’s consumption went well beyond the occasional use he previously admitted, with sources claiming frequent ketamine use that affected his health. Understanding these claims provides insight into Musk’s recent behavior and the intense scrutiny surrounding one of the world’s most high-profile tech leaders.
The New York Times investigation, based on interviews with over a dozen people close to Musk and private messages reviewed by the publication, suggests that Musk sometimes used ketamine daily. This contrasts sharply with his own earlier statements describing ketamine use as “once every two weeks” to treat depression. Chronic ketamine use is known to cause bladder issues, which Musk reportedly experienced. Sources also mentioned that Musk combined ketamine with a range of other unspecified substances, pointing to a more complex and concerning pattern of drug use than publicly acknowledged.
Musk’s drug habits reportedly coincided with his endorsement of Donald Trump’s 2024 presidential run, during which he openly discussed his ketamine use affecting his physical health. Concerns raised by those close to him include mood swings and an obsession with having more children, illustrating the broader impact on his personal life and decision-making. Despite strict drug testing requirements at companies like SpaceX, insiders told The Times that Musk often received advanced notice of tests, allowing him to avoid detection.
Further insights from a Wall Street Journal report in January 2024 revealed Musk’s use of other potent substances such as LSD, cocaine, ecstasy, and psychedelic mushrooms, particularly at private global parties with strict confidentiality protocols. Tesla board members have privately expressed concern about his drug use over the years, complicated by the fact that some of Musk’s closest friends—who attend these gatherings—are also company insiders.
This deep dive into Elon Musk’s drug use highlights the complex interplay between high-stress leadership, personal challenges, and substance use among tech industry giants. For those searching for the truth behind Musk’s public persona and company leadership, these revelations add crucial context. Keeping an eye on how these issues may affect Tesla, SpaceX, and other ventures is vital for investors, tech enthusiasts, and followers of innovation.
